Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Drescher

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 5, 2018
First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteersYuanyuan Jiao, Tae Hwan Kim, Xun Tao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2020
Upregulation of virulence genes promotes <i>Vibrio cholerae</i> biofilm hyperinfectivityA L Gallego-Hernandez, W H DePas, J H Park, et al.
Frontiers in Physiology|July 12, 2019
The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)Hannah K Drescher, Ralf Weiskirchen, Annabelle Fülöp, et al.
Frontiers in Physiology|April 12, 2019
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in MiceHannah K Drescher, Elisa F Brandt, Petra Fischer, et al.
Clinical Pharmacokinetics|June 25, 2018
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic FibrosisJürgen B Bulitta, Yuanyuan Jiao, Stefanie K Drescher, et al.
Cells|May 6, 2020
L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and MenHannah K Drescher, Angela Schippers, Stefanie Rosenhain, et al.
Science Translational Medicine|September 21, 2022
Molecular MRI quantification of extracellular aldehyde pairs for early detection of liver fibrogenesis and response to treatmentYingying Ning, Iris Y Zhou, Jesse D Roberts, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 5, 2022
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisStephanie A Osganian, Sonu Subudhi, Ricard Masia, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 2, 2005
Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonistsM Cowart, R Faghih, G Gfesser, et al.
Journal of Hepatology|June 18, 2022
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen<sup>+</sup> infectionRuben C Hoogeveen, Suzan Dijkstra, Lea M Bartsch, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 5, 2018
First population pharmacokinetic analysis showing increased quinolone metabolite formation and clearance in patients with cystic fibrosis compared to healthy volunteersYuanyuan Jiao, Tae Hwan Kim, Xun Tao, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2020
Upregulation of virulence genes promotes <i>Vibrio cholerae</i> biofilm hyperinfectivityA L Gallego-Hernandez, W H DePas, J H Park, et al.
Frontiers in Physiology|July 12, 2019
The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)Hannah K Drescher, Ralf Weiskirchen, Annabelle Fülöp, et al.
Frontiers in Physiology|April 12, 2019
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in MiceHannah K Drescher, Elisa F Brandt, Petra Fischer, et al.
Clinical Pharmacokinetics|June 25, 2018
Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic FibrosisJürgen B Bulitta, Yuanyuan Jiao, Stefanie K Drescher, et al.
Cells|May 6, 2020
L-Selectin/CD62L is a Key Driver of Non-Alcoholic Steatohepatitis in Mice and MenHannah K Drescher, Angela Schippers, Stefanie Rosenhain, et al.
Science Translational Medicine|September 21, 2022
Molecular MRI quantification of extracellular aldehyde pairs for early detection of liver fibrogenesis and response to treatmentYingying Ning, Iris Y Zhou, Jesse D Roberts, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|July 5, 2022
Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitisStephanie A Osganian, Sonu Subudhi, Ricard Masia, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 2, 2005
Achievement of behavioral efficacy and improved potency in new heterocyclic analogs of benzofuran H3 antagonistsM Cowart, R Faghih, G Gfesser, et al.
Journal of Hepatology|June 18, 2022
Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen<sup>+</sup> infectionRuben C Hoogeveen, Suzan Dijkstra, Lea M Bartsch, et al.
Pageof 6